Bisindolylmaleimide VIII CAS: 138516-31-1
MF: C24H22N4O2•C2H4O2
Bisindolylmaleimide VIII is a selective PKC inhibitor.

Bisindolylmaleimide VIII (CAS 138516-31-1)

Bisindolylmaleimide VIII | CAS 138516-31-1 is rated 5.0 out of 5 by 1.
  • y_2022, m_8, d_13, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.32
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_24005, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 109ms
  • REVIEWS, PRODUCT
loading
5
1
4
0
3
0
2
0
1
0
Alternate Names: Ro 31-7549 acetate
Application: Bisindolylmaleimide VIII is a selective PKC inhibitor
CAS Number: 138516-31-1
Purity: ≥98%
Molecular Weight: 458.60
Molecular Formula: C24H22N4O2•C2H4O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).
loading

Bisindolylmaleimide VIII is a selective PKC (protein kinase C) inhibitor, with observed binding activity to dystrophia myotonica protein kinase (DMPK). Bisindolylmaleimide VIII is suggested as being slightly more specific for PKC α over PKC β, PKC γ, and PKC ε isozymes (IC50 = 53, 195, 213, and 275 respectively). The compound has been shown to improve DR5-mediated apoptosis through the MKK4/JNK/p38 kinase. When bisindolylmaleimide VIII is combined with TRA-8 it can activate c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase. Studies have shown that bisindolylmaleimide VIII enhance Fas-mediated apoptosis in both human astrocytoma 1321N1 cells and in Molt-4T cells.


References

1. Zhou, T., et al. 1999. Nat. Med. 5: 42-48. PMID: 9883838

2. Ohtsuka, T. and Zhou, T. 2002. J. Biol. Chem. 277: 29294-29303. PMID: 12034736

3. Lautrette, C., et al. 2006. Apoptosis. 11: 1195-1204. PMID: 16699962

4. Elkins, J.M., et al. 2009. Protein Sci. 18: 782-791. PMID: 19309729

Appearance :
Crystalline
Physical State :
Solid
Solubility :
Soluble in DMSO, methanol, water, and 100% ethanol (slightly).
Storage :
Store at -20° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
MDL Number :
MFCD00909467
SMILES :
CC(=O)O.CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)CCCN

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Bisindolylmaleimide VIII (CAS 138516-31-1)  Product Citations

See how others have used Bisindolylmaleimide VIII (CAS 138516-31-1). Click on the entry to view the PubMed entry .

Citations 1 to 6 of 6 total

PMID: # 33250241  Ha, M.|Huang, X.|Li, L.|Lu, D.|Liu, C.| et al. 2021. Sci Total Environ. 757: 143727.

PMID: # 25355318  Wang, Y. et al. 2014. The Journal of biological chemistry. 289: 35795-805.

PMID: # 22847994  2013. J Biomed Mater Res A. 101: 378-84.

PMID: # 19309729  Elkins, JM. et al. 2009. Protein Sci. 18: 782-791.

PMID: # 16352573  Park, R. et al. 2006. J. Virol. 80: 495-504.

PMID: # 27696749  Andrology. 1073-1083.

Citations 1 to 6 of 6 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 103ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Elkins JM; et al Elkins JM; et al. (PubMed ID: 19309729) determined that the Dystrophia myotonica protein kinase bound to its inhibitor, bisindolylmaleimide VIII (BIM-8), occupies the ATP site and has analogous binding mode as observed in PDK1. -SCBT Publication Review
Date published: 2015-01-22
  • y_2022, m_8, d_13, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.32
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_24005, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 24ms
  • REVIEWS, PRODUCT